AUG 25·SEC EDGAR 8-KLow
BiomX Inc. (PHGE): Submission of Matters to a Vote of Security Holders
BiomX Inc. (PHGE) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders.
StockNYSE · US · USDHealthcare · Biotechnology
$PHGE
BiomX Inc.
Price · $PHGEvia TradingView
AI sentiment · 7d1 articles
- Bullish
- 0
- Neutral
- 1
- Bearish
- 0
Insider · 30dAll trades →
No SEC Form 4 filings for $PHGE in the last 30 days.
See all $PHGE insider activity →Top stories · $PHGEMore →
AUG 19·tradingview.com
BiomX Inc. 2Q 2026: Revenue $0.33M, Net loss $3.85M, EPS ($0.36) — 10-Q Summary
BiomX Inc. reported 2Q 2026 revenue of $0.33M, a net loss of $3.85M, and EPS of ($0.36). This marks the company's first quarter of revenue following April acquisitions. The company shifted focus to defense and security markets, with products deployed in pilots and operational sites. Management is pursuing a mixed monetization approach. According to the SEC filing, the company consolidated results from DFSL and ZorroNet from April 2026.
AUG 14·finanznachrichten.de
BiomX Subsidiary Zorronet Receives Approximately $300,000 Purchase Order to Build Unified Operational Environment at Defense Technology Test and Evaluation Site
BiomX Inc. (NYSE American: PHGE) said its subsidiary Zorronet Ltd. received an approximately $300,000 order to plan, integrate and deploy a unified command-and-control environment at a defense technology test and evaluation site. Zorronet will build communications, computing and control infrastructure and integrate multiple systems, managing the project end to end.
PHGE sentiment & insider activity
Over the past 7 days, alphai's AI scored 1 news story mentioning PHGE (BiomX Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent PHGE coverage spans corporate actions, financial news and mergers & acquisitions.
What's driving PHGE
The filing indicates upcoming shareholder voting, but no immediate financial impact.
BiomX Inc. reported 2Q 2026 revenue of $0.33M, a net loss of $3.85M, and EPS of ($0.36). This marks the company's first quarter of revenue following April acquisitions. The company shifted focus to defense and security markets, with products deployed in pilots and operational sites. Management is pursuing a mixed monetization approach. According to the SEC filing, the company consolidated results from DFSL and ZorroNet from April 2026.
A small but concrete defense-related systems-integration contract suggests incremental traction for Zorronet and supports the company’s business-plan execution narrative.
The 8-K discloses a structured acquisition option tied to 2027 Net Revenue or EBITDA, creating a new path to control of MEA testing technology.
The amendment reduces near-term default risk but introduces dilution over a defined longstop (Aug 31, 2026) if approvals clear.
alphai scores every news story that mentions PHGE with an AI model for sentiment and relevance, and aggregates insider trades from BiomX Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $PHGE
Score
BiomX Inc. (PHGE): Submission of Matters to a Vote of Security Holders
BiomX Inc. (PHGE) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders.
1 min read
BiomX Inc. 2Q 2026: Revenue $0.33M, Net loss $3.85M, EPS ($0.36) — 10-Q Summary
BiomX Inc. reported 2Q 2026 revenue of $0.33M, a net loss of $3.85M, and EPS of ($0.36). This marks the company's first quarter of revenue following April acquisitions. The company shifted focus to defense and security markets, with products deployed in pilots and operational sites. Management is pursuing a mixed monetization approach. According to the SEC filing, the company consolidated results from DFSL and ZorroNet from April 2026.
1 min readBiomX Subsidiary Zorronet Receives Approximately $300,000 Purchase Order to Build Unified Operational Environment at Defense Technology Test and Evaluation Site
BiomX Inc. (NYSE American: PHGE) said its subsidiary Zorronet Ltd. received an approximately $300,000 order to plan, integrate and deploy a unified command-and-control environment at a defense technology test and evaluation site. Zorronet will build communications, computing and control infrastructure and integrate multiple systems, managing the project end to end.
2 min readBiomX Inc. (PHGE): Entry into a Material Definitive Agreement
BiomX Inc. (PHGE) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 ea030154401ex10-1.htm SHARE PURCHASE AND OPTION AGREEMENT DATED AUGUST 5, 2026 BETWEEN BIOMX INC. AND MAYERS VENTURES LLC Exhibit 10.1 SHARE PURCHASE AND OPTION AGREEMENT (M.E.A. Testing Systems Ltd. Equity) This Share Purchase and Option Agreement (this “Agreement”) is
4 min readBiomX Inc. (PHGE): Entry into a Material Definitive Agreement
BiomX Inc. (PHGE) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. false 0001739174 0001739174 2026-07-27 2026-07-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Repor
3 min readBiomX' Subsidiary Zorronet Expands European Presence Through Strategic Collaboration
BiomX Inc. (PHGE) said its subsidiary Zorronet Ltd. entered two European collaborations. With Samura s.r.o., it will develop AI monitoring for agriculture and urban pest management using sensor and camera data. With a transportation-infrastructure partner, it will use AI to detect hazards, animals, and unauthorized people to support faster responses. PHGE reported a 1-for-19 reverse split on Nov. 24, 2025; shares closed at $0.18.
3 min read
BiomX: Zorronet Completes Transition to New Advanced Data Center Supporting Business Expansion and Enhanced AI Capabilities
BiomX Inc. (NYSE American: PHGE) said its wholly owned subsidiary Zorronet completed a transition of core operations to a new data center. The company says it is built to improve response times, cost efficiency, and real-time capacity for complex security events, supporting Zorronet’s AI command-and-control platform and business expansion.
2 min read
BiomX (PHGE) Stock Soars Over 25% After-Hours: Here's Why it is Trending - BiomX (AMEX:PHGE)
BiomX Inc. (NYSE:PHGE) shares rose 25.24% to $0.35 after hours after the company said its subsidiary signed a non-binding LOI to buy 60% of Tsoock Defense Technologies for $10.4 million. Terms include a $300,000 initial payment, quarterly installments, and an option to buy the remaining 40% for $9.2 million within 36 months. BiomX cited Tsoock 2025 revenue of NIS 13.1M (+70%) and profit of NIS 625k.
5 min readBiomX Sings LOI To Acquire Majority Stake In Israeli Security Systems Integrator; Stock Down
BiomX Inc. (PHGE) said its subsidiary signed a non-binding LOI to buy a 60% controlling stake in Tsoock Defense Technologies Ltd. for $10.4 million, with an initial $300,000 payment and four quarterly installments. Tsoock reported 2025 revenue of about NIS 13.1 million (+70%) and net profit of NIS 625,000. BiomX may buy the remaining 40% for $9.2 million within 36 months. PHGE shares fell after the news.
4 min readBiomX Subsidiary Inks LoI To Acquire 60% Stake In Tsoock For $10.4 Mln
BiomX Inc. (PHGE) said its subsidiary BiomX Israel Defense and Security signed a non-binding LoI to buy a 60% controlling stake in Tsoock Defense Technologies for $10.4 million. The deal includes $300,000 upfront and $10.1 million in four quarterly installments over 12 months, with an option to buy the remaining 40% for $9.2 million. Tsoock reported NIS 625k profit in 2025 vs NIS 1.8m loss in 2024.
4 min read